Viatris has faced volatility since its 2020 formation but is now in Phase 2 of its transformation. Learn why VTRS stock could ...

KeyBanc lowered the firm’s price target on Alcon (ALC) to $105 from $107 and keeps an Overweight rating on the shares. The firm remains ...

Check OneSource Specialty Pharma Stock Price live NSE/BSE on financialexpress.com. Get OneSource Specialty Pharma today's stock price, 52-week high, 52-week low, OneSource Specialty Pharma quarterly ...

Biocon share price gained 2.61 per cent at Rs 398 a piece on the BSE in Thursday’s intraday trade. This came after the ...

Scotiabank analyst Greg Harrison raised the firm’s price target on Disc Medicine (IRON) to $73 from $70 and keeps an Outperform rating on the ...

Biocon stock price is poised for a fresh breakout from its consolidation range of 320-395, following nearly three and a half ...

Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu.

Bajaj Finserv Ltd. has garnered multiple buy recommendations from various analysts, all predicting an upward movement in the ...

India should eliminate tax on drugs for cancer treatment and for chronic and rare diseases, the chairperson of major ...

Raising overseas debt has become prohibitively expensive due to the depreciating rupee, he explained, adding, "several Indian ...

Biocon’s shares surged over 7% on January 14, 2025, after HSBC upgraded its rating to ’Buy’ with a target price of ₹430, ...

HSBC's base case target suggests 10 per cent upside over the prevailing stock price. Its bull case target suggests 40 per ...